Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 1,071 $ 4,787
Marketable debt securities 7,039 8,969
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 2,129 1,737
Total current assets 10,289 15,543
Non-current assets:    
Leasehold improvements and equipment – net 1,829 1,923
Operating lease right-of-use assets – net 2,919 3,064
Finance lease right-of-use assets – net 20 21
In-process research and development 3,017 3,017
Goodwill 1,336 1,336
Restricted cash – security deposit 200 200
Total non-current assets 9,321 9,561
Total assets 19,610 25,104
Current liabilities:    
Accounts payable 473 514
Accrued expenses 839 1,447
Operating lease liabilities – current 681 656
Financing lease liabilities – current 5 5
Total current liabilities 1,998 2,622
Non-current liabilities:    
Deferred tax liability 341 341
Operating lease liabilities – net of current portion 2,697 2,877
Financing lease liabilities – net of current portion 16 18
Total non-current liabilities 3,054 3,236
Total liabilities 5,052 5,858
Stockholders’ equity:    
Common stock par value $0.0001 per share, 500,000,000 shares authorized at March 31, 2024 and December 31, 2023; 217,482,830 and 217,264,526 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively 22 22
Additional paid-in capital 196,067 195,018
Accumulated deficit (181,397) (175,573)
Accumulated other comprehensive loss (134) (221)
Total stockholders’ equity 14,558 19,246
Total liabilities and stockholders’ equity $ 19,610 $ 25,104